+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

  • PDF Icon

    Report

  • 261 Pages
  • April 2024
  • Region: Global
  • Azoth Analytics
  • ID: 5950192
Description Jump to:
This report provides a complete analysis of the Global Infectious Disease In vitro Diagnostics industry in terms of market segmentation by Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type (Instruments, Reagents, and Services) By End Users (Point of care, Central Laboratories, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Infectious Disease In vitro Diagnostics market showcased growth at a CAGR of 2.45 % during 2020-2023. The market was valued at USD 65.86 Billion in 2023 which is expected to reach USD 80.31 Billion in 2030. Growing disposable income levels, particularly among affluent consumers, have fuelled demand for premium anti-aging services and skincare products.

The global market for infectious disease in-vitro diagnostics encompasses a wide range of diagnostic tests and technologies used for the detection and management of infectious diseases. It includes various assays, instruments, and reagents designed to identify pathogens, such as bacteria, viruses, fungi, and parasites, responsible for causing infectious illnesses in humans. These diagnostic tools play a crucial role in disease surveillance, outbreak control, patient management, and public health interventions worldwide.

The market for infectious disease in-vitro diagnostics is driven by several factors, including the increasing prevalence of infectious diseases, rising demand for rapid and accurate diagnostic solutions, advancements in diagnostic technologies, and growing awareness about the importance of early disease detection and intervention.

Additionally, factors such as globalization, urbanization, population growth, and environmental changes contribute to the spread of infectious pathogens, further fueling the demand for diagnostic tests and tools.

The market is characterized by intense competition among key players, including diagnostic manufacturers, biotechnology companies, and healthcare organizations. These companies are continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report

  • The report analyses the Infectious Disease In vitro Diagnostics Market by Value (USD Billion).
  • The report presents the analysis of Infectious Disease In vitro Diagnostics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The report analyses the Infectious Disease In vitro Diagnostics Market By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies)
  • The report analyses the Infectious Disease In vitro Diagnostics Market By Product Type (Instruments, Reagents, and Services).
  • The report analyses the Infectious Disease In vitro Diagnostics Market By End Users (Point of care, Central Laboratories, and Other End Uses).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Technology, By Product Type and By End User.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include QIAGEN, F. Hoffmann-La Roche AG, OraSure technologies, PerkinElmer Inc., Abbott Laboratories, Thermo Fisher, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation, and Bio-Rad Laboratories

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Investment in Education and Training
2.2 Leveraging Artificial Intelligence for Advancements in Infectious Disease In-Vitro Diagnostics
3. Global Infectious Disease In vitro Diagnostics Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Infectious Disease In vitro Diagnostics Market
3.2 Global Prevalence of Infectious Disease, 2019
3.3 Global Incidence of Infectious Disease, 2019
3.4 New cases of tuberculosis with uncertainty intervals, World (2020-2022)
3.5 SARS-Cov-2 Tests: Volumes 2020
3.6 Global Infectious Disease In vitro Diagnostics Market: Dashboard
3.7 Global Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
3.8 Global Infectious Disease In vitro Diagnostics Market: Market Value Assessment
3.9 Assessment Degree of Impact of COVID-19 on Global Infectious Disease In vitro Diagnostics Market
3.10 Global Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
3.10.1 Global Infectious Disease In vitro Diagnostics Market, By Technology Overview
3.10.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By Technology
3.10.3 Global Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.4 Global Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.5 Global Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.6 Global Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
3.11 Global Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
3.11.1 Global Infectious Disease In vitro Diagnostics Market, By Product Type Overview
3.11.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By Product Type
3.11.3 Global Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.4 Global Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.5 Global Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
3.12 Global Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
3.12.1 Global Infectious Disease In vitro Diagnostics Market, By End-users Overview
3.12.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By End-users
3.12.3 Global Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
3.12.4 Global Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
3.12.5 Global Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
4. Global Infectious Disease In vitro Diagnostics Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Infectious Disease In vitro Diagnostics Market: Historic and Forecast
5.1 Americas Infectious Disease In vitro Diagnostics Market: Snapshot
5.2 Americas Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.3 Americas Infectious Disease In vitro Diagnostics Market: Key Factors
5.4 Americas Infectious Disease In vitro Diagnostics Market: Segment Analysis
5.5 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
5.5.1 Americas Infectious Disease In vitro Diagnostics Market, By Technology Overview
5.5.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.5 Americas Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
5.6.1 Americas Infectious Disease In vitro Diagnostics Market, By Product Type Overview
5.6.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
5.7.1 Americas Infectious Disease In vitro Diagnostics Market, By End-users Overview
5.7.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
5.8 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Country
5.8.1 Americas Infectious Disease In vitro Diagnostics Market, by Country Overview
5.8.2 United States Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.2.1 United States Infectious Disease In vitro Diagnostics Market, By Technology
5.8.2.2 United States Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.2.3 United States Infectious Disease In vitro Diagnostics Market, By End-users
5.8.3 Canada Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.3.1 Canada Infectious Disease In vitro Diagnostics Market, By Technology
5.8.3.2 Canada Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.3.3 Canada Infectious Disease In vitro Diagnostics Market, By End-users
5.8.4 Rest of Americas Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.4.1 Rest of Americas Infectious Disease In vitro Diagnostics Market, By Technology
5.8.4.2 Rest of Americas Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.4.3 Rest of Americas Infectious Disease In vitro Diagnostics Market, By End-users
6. Europe Infectious Disease In vitro Diagnostics Market: Historic and Forecast
6.1 Europe Infectious Disease In vitro Diagnostics Market: Snapshot
6.2 Europe Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.3 Europe Infectious Disease In vitro Diagnostics Market: Key Factors
6.4 Europe Infectious Disease In vitro Diagnostics Market: Segment Analysis
6.5 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
6.5.1 Europe Infectious Disease In vitro Diagnostics Market, By Technology Overview
6.5.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.4 Europe Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.5 Europe Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
6.6.1 Europe Infectious Disease In vitro Diagnostics Market, By Product Type Overview
6.6.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
6.7.1 Europe Infectious Disease In vitro Diagnostics Market, By End-users Overview
6.7.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.4 Europe Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
6.8 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Country
6.8.1 Europe Infectious Disease In vitro Diagnostics Market, by Country Overview
6.8.2 Germany Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.2.1 Germany Infectious Disease In vitro Diagnostics Market, By Technology
6.8.2.2 Germany Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.2.3 Germany Infectious Disease In vitro Diagnostics Market, By End-users
6.8.3 United Kingdom Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.3.1 United Kingdom Infectious Disease In vitro Diagnostics Market, By Technology
6.8.3.2 United Kingdom Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.3.3 United Kingdom Infectious Disease In vitro Diagnostics Market, By End-users
6.8.4 France Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.4.1 France Infectious Disease In vitro Diagnostics Market, By Technology
6.8.4.2 France Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.4.3 France Infectious Disease In vitro Diagnostics Market, By End-users
6.8.5 Italy Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.5.1 Italy Infectious Disease In vitro Diagnostics Market, By Technology
6.8.5.2 Italy Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.5.3 Italy Infectious Disease In vitro Diagnostics Market, By End-users
6.8.6 Spain Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.6.1 Spain Infectious Disease In vitro Diagnostics Market, By Technology
6.8.6.2 Spain Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.6.3 Spain Infectious Disease In vitro Diagnostics Market, By End-users
6.8.7 Rest of Europe Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.7.1 Rest of Europe Infectious Disease In vitro Diagnostics Market, By Technology
6.8.7.2 Rest of Europe Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.7.3 Rest of Europe Infectious Disease In vitro Diagnostics Market, By End-users
7. Asia Pacific Infectious Disease In vitro Diagnostics Market: Historic and Forecast
7.1 Asia Pacific Infectious Disease In vitro Diagnostics Market: Snapshot
7.2 Asia Pacific Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Infectious Disease In vitro Diagnostics Market: Key Factors
7.4 Asia Pacific Infectious Disease In vitro Diagnostics Market: Segment Analysis
7.5 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
7.5.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology Overview
7.5.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.4 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.6 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
7.6.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type Overview
7.6.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
7.7.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users Overview
7.7.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.4 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
7.8 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Country
7.8.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, by Country Overview
7.8.2 China Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.2.1 China Infectious Disease In vitro Diagnostics Market, By Technology
7.8.2.2 China Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.2.3 China Infectious Disease In vitro Diagnostics Market, By End-users
7.8.3 Japan Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.3.1 Japan Infectious Disease In vitro Diagnostics Market, By Technology
7.8.3.2 Japan Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.3.3 Japan Infectious Disease In vitro Diagnostics Market, By End-users
7.8.4 India Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.4.1 India Infectious Disease In vitro Diagnostics Market, By Technology
7.8.4.2 India Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.4.3 India Infectious Disease In vitro Diagnostics Market, By End-users
7.8.5 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.5.1 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology
7.8.5.2 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.5.3 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users
8. Middle East and Africa Infectious Disease In vitro Diagnostics Market: Historic and Forecast
8.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Snapshot
8.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Key Factors
8.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Segment Analysis
8.5 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
8.5.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Technology Overview
8.5.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.5 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
8.6.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Product Type Overview
8.6.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
8.7 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
8.7.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By End-users Overview
8.7.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Infectious Disease In vitro Diagnostics Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Infectious Disease In vitro Diagnostics Market
11.4 Company Profiles
11.4.1 QIAGEN
11.4.2 F. Hoffmann-La Roche AG
11.4.3 OraSure technologies
11.4.4 PerkinElmer Inc.
11.4.5 Abbott Laboratories
11.4.6 Thermo Fisher
11.4.7 Becton, Dickinson and Company
11.4.8 Hologic, Inc.
11.4.9 Danaher Corporation
11.4.10 Bio-Rad Laboratories
12. About Us & Disclaimer
List of Figures
Figure 1: Global Prevalence of Infectious Disease, 2019
Figure 2: Global Incidence of Infectious Disease, 2019
Figure 3: New cases of tuberculosis with uncertainty intervals, World
Figure 4: Global Infectious Disease In vitro Diagnostics Market Size, By Value, 2020-2023 (USD Billion)
Figure 5: Global Infectious Disease In vitro Diagnostics Market Size, By Value, 2024-2030 (USD Billion)
Figure 6: Global Infectious Disease In vitro Diagnostics Market Share, By End-users, 2023 (%)
Figure 7: Market Attractiveness Analysis of Global Infectious Disease In vitro Diagnostics Market, By Technology (2025-2030)
Figure 8: Global Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 9: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Immunoassay, 2020-2030 (USD Billion)
Figure 10: Global Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 11: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Molecular Diagnostics, 2020-2030 (USD Billion)
Figure 12: Global Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 13: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Microbiology, 2020-2030 (USD Billion)
Figure 14: Global Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 15: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Other Technologies, 2020-2030 (USD Billion)
Figure 16: Market Attractiveness Analysis of Global Infectious Disease In vitro Diagnostics Market, By Product Type (2025-2030)
Figure 17: Global Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 18: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Instruments, 2020-2030 (USD Billion)
Figure 19: Global Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 20: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Reagents, 2020-2030 (USD Billion)
Figure 21: Global Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 22: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Services, 2020-2030 (USD Billion)
Figure 23: Market Attractiveness Analysis of Global Infectious Disease In vitro Diagnostics Market, By End-users (2025-2030)
Figure 24: Global Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 25: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Point of care, 2020-2030 (USD Billion)
Figure 26: Global Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 27: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Central Laboratories, 2020-2030 (USD Billion)
Figure 28: Global Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 29: Global Infectious Disease In vitro Diagnostics Market Absolute Opportunity, By Other End-users, 2020-2030 (USD Billion)
Figure 30: Americas Infectious Disease In vitro Diagnostics Market Size, By Value, 2020H-2030F (USD Billion)
Figure 31: Americas Infectious Disease In vitro Diagnostics Market Share, By End-users, 2023 (%)
Figure 32: Americas Infectious Disease In vitro Diagnostics Market, By Immunoassay, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 33: Americas Infectious Disease In vitro Diagnostics Market, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 34: Americas Infectious Disease In vitro Diagnostics Market, By Microbiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 35: Americas Infectious Disease In vitro Diagnostics Market, By Other Technologies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 36: Americas Infectious Disease In vitro Diagnostics Market, By Instruments, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 37: Americas Infectious Disease In vitro Diagnostics Market, By Reagents, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 38: Americas Infectious Disease In vitro Diagnostics Market, By Services, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 39: Americas Infectious Disease In vitro Diagnostics Market, By Point of care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 40: Americas Infectious Disease In vitro Diagnostics Market, By Central Laboratories, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 41: Americas Infectious Disease In vitro Diagnostics Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 42: United States Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 43: United States Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 44: United States Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 45: United States Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 46: United States Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 47: Canada Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 48: Canada Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 49: Canada Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 50: Canada Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 51: Canada Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 52: Rest of Americas Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 53: Rest of Americas Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 54: Rest of Americas Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 55: Rest of Americas Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 56: Rest of Americas Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 57: Europe Infectious Disease In vitro Diagnostics Market Size, By Value, 2020H-2030F (USD Billion)
Figure 58: Europe Infectious Disease In vitro Diagnostics Market Share, By End-users, 2023 (%)
Figure 59: Europe Infectious Disease In vitro Diagnostics Market, By Immunoassay, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 60: Europe Infectious Disease In vitro Diagnostics Market, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 61: Europe Infectious Disease In vitro Diagnostics Market, By Microbiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 62: Europe Infectious Disease In vitro Diagnostics Market, By Other Technologies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 63: Europe Infectious Disease In vitro Diagnostics Market, By Instruments, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 64: Europe Infectious Disease In vitro Diagnostics Market, By Reagents, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 65: Europe Infectious Disease In vitro Diagnostics Market, By Services, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 66: Europe Infectious Disease In vitro Diagnostics Market, By Point of care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 67: Europe Infectious Disease In vitro Diagnostics Market, By Central Laboratories, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 68: Europe Infectious Disease In vitro Diagnostics Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 69: Germany Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 70: Germany Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 71: Germany Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 72: Germany Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 73: Germany Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 74: United Kingdom Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 75: United Kingdom Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 76: United Kingdom Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 77: United Kingdom Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 78: United Kingdom Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 79: France Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 80: France Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 81: France Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 82: France Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 83: France Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 84: Italy Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 85: Italy Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 86: Italy Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 87: Italy Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 88: Italy Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 89: Spain Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 90: Spain Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 91: Spain Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 92: Spain Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 93: Spain Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 94: Rest of Europe Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 95: Rest of Europe Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 96: Rest of Europe Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 97: Rest of Europe Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 98: Rest of Europe Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 99: Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Value, 2020H-2030F (USD Billion)
Figure 100: Asia Pacific Infectious Disease In vitro Diagnostics Market Share, By End-users, 2023 (%)
Figure 101: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Immunoassay, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 102: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 103: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Microbiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 104: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Other Technologies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 105: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Instruments, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 106: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Reagents, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 107: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Services, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 108: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Point of care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 109: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Central Laboratories, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 110: Asia Pacific Infectious Disease In vitro Diagnostics Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 111: China Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 112: China Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 113: China Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 114: China Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 115: China Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 116: Japan Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 117: Japan Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 118: Japan Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 119: Japan Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 120: Japan Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 121: India Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 122: India Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 123: India Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 124: India Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 125: India Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 126: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 127: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market Value, By Product Type, 2023 (USD Billion)
Figure 128: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market Share, By Technology, By Value, 2023 (%)
Figure 129: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market Share, By Product Type, By Value, 2023 (%)
Figure 130: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market Share, By End-users, By Value, 2023 (%)
Figure 131: Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Value, 2020H-2030F (USD Billion)
Figure 132: Middle East and Africa Infectious Disease In vitro Diagnostics Market Share, By End-users, 2023 (%)
Figure 133: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Immunoassay, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 134: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 135: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Microbiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 136: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Other Technologies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 137: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Instruments, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 138: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Reagents, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 139: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Services, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 140: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Point of care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 141: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Central Laboratories, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 142: Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 143: Market Share of Prominent Companies of Global Infectious Disease In vitro Diagnostics Market, 2023 (%)
Figure 144: Qiagen Revenues, 2020-2022 (USD Million)
Figure 145: Qiagen Revenue, By Customer class , 2022 (%)
Figure 146: Qiagen Revenue , By Geographical Segments, 2022 (%)
Figure 147: Roche Revenues, 2021-2023 (USD Million)
Figure 148: Roche Revenue , By Sales Division, 2023 (%)
Figure 149: Roche Revenue , By Geographical Segment, 2023 (%)
Figure 150: OraSure technologies Revenues, 2021-2023 (USD Million)
Figure 151: OraSure technologies Revenue , By Geographic Segment, 2023 (%)
Figure 152: OraSure technologies Revenue , By Business Segment, 2023 (%)
Figure 153: Abbott Laboratories Revenues, 2021-2023 (USD Million)
Figure 154: Abbott Laboratories Revenues, By Geographic Segments, 2023 (%)
Figure 155: Abbott Laboratories Revenue , By Business Segments, 2023 (%)
Figure 156: Thermo Fisher Revenues, 2020-2022 (USD Million)
Figure 157: Thermo Fisher Revenue , By Geographic segment, 2022 (%)
Figure 158: Thermo Fisher Revenue , By Business Segments, 2022 (%)
Figure 159: Becton, Dickinson and Company Revenues, 2021-2023 (USD Million)
Figure 160: Becton, Dickinson and Company Revenue , By Geographic segment, 2023 (%)
Figure 161: Becton, Dickinson and Company Revenue , By Business Segments, 2023 (%)
Figure 162: Hologic Revenues, 2020-2022 (USD Million)
Figure 163: Hologic Revenue , By Business Segment, 2023 (%)
Figure 164: Hologic Revenue , By Geographical Segments, 2023 (%)
Figure 165: Danaher Revenues, 2020-2022 (USD Million)
Figure 166: Danaher Revenue , By Business Segment, 2022 (%)
Figure 167: Danaher Revenue , By Geographical Segments, 2022 (%)
Figure 168: Bio-Rad Revenues, 2020-2022 (USD Million)
Figure 169: Bio-Rad Revenue , By Business Segment, 2022 (%)
Figure 170: Bio-Rad Revenue , By Geographical Segments, 2022 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: SARS-Cov-2 Tests: Volumes 2020
Table A3: United States Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A4: United States Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A5: United States Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A6: United States Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A7: United States Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A8: United States Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A9: Canada Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A10: Canada Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A11: Canada Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A12: Canada Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A13: Canada Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A14: Canada Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A15: Rest of Americas Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A16: Rest of Americas Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A17: Rest of Americas Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A18: Rest of Americas Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A19: Rest of Americas Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A20: Rest of Americas Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A21: Germany Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A22: Germany Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A23: Germany Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A24: Germany Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A25: Germany Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A26: Germany Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A27: United Kingdom Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A28: United Kingdom Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A29: United Kingdom Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A30: United Kingdom Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A31: United Kingdom Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A32: United Kingdom Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A33: France Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A34: France Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A35: France Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A36: France Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A37: France Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A38: France Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A39: Italy Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A40: Italy Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A41: Italy Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A42: Italy Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A43: Italy Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A44: Italy Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A45: Spain Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A46: Spain Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A47: Spain Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A48: Spain Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A49: Spain Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A50: Spain Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A51: Rest of Europe Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A52: Rest of Europe Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A53: Rest of Europe Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A54: Rest of Europe Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A55: Rest of Europe Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A56: Rest of Europe Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A57: China Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A58: China Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A59: China Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A60: China Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A61: China Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A62: China Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A63: Japan Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A64: Japan Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A65: Japan Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A66: Japan Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A67: Japan Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A68: Japan Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A69: India Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A70: India Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A71: India Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A72: India Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A73: India Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A74: India Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A75: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2020-2023 (USD Billion)
Table A76: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology, By Value, 2025-2030 (USD Billion)
Table A77: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2020-2023 (USD Billion)
Table A78: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type, By Value, 2025-2030 (USD Billion)
Table A79: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2020-2023 (USD Billion)
Table A80: Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users, By Value, 2025-2030 (USD Billion)
Table A81: Qiagen Company Financials, 2020-2022
Table A82: Roche Key Financials, 2021-2023
Table A83: OraSure technologies Key Financials, 2021-2023
Table A84: Abbott Laboratories Key Financials, 2021-2023
Table A85: Thermo Fisher Key Financials, 2020-2022
Table A86: Becton, Dickinson and Company Key Company Financials, 2021-2023
Table A87: Hologic Company Financials, 2020-2022
Table A88: Danaher Company Financials, 2020-2022
Table A89: Bio-Rad Company Financials, 2020-2022

Companies Mentioned

  • QIAGEN
  • F. Hoffmann-La Roche AG
  • OraSure Technologies
  • PerkinElmer Inc.
  • Abbott Laboratories
  • Thermo Fisher
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories

Related Topics

Related Reports

Infectious Diseases In-Vitro Diagnostics Market by Product, Technology, Indication, End-user - Global Forecast 2025-2030 - Product Image

Infectious Diseases In-Vitro Diagnostics Market by Product, Technology, Indication, End-user - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Software), Technology, Application, Test Location, Region, and Segment Forecasts, 2024-2030 - Product Image

Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Software), Technology, Application, Test Location, Region, and Segment Forecasts, 2024-2030

  • Report
  • 190 Pages
  • Global
From
Infectious Disease In-vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Infectious Disease In-vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029 - Product Image

In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029

  • Report
  • 677 Pages
  • Global
From
Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the IVD Infectious Disease Market

The In Vitro Diagnostics (IVD) Infectious Disease market is a segment of the larger IVD industry that focuses on the diagnosis and monitoring of infectious diseases. It includes a range of products and services, such as tests for the detection of bacteria, viruses, fungi, and parasites, as well as tests for the identification of drug-resistant organisms. These tests are used to diagnose and monitor the progression of infectious diseases, as well as to guide treatment decisions. The IVD Infectious Disease market is driven by the increasing prevalence of infectious diseases, the emergence of new and drug-resistant pathogens, and the need for rapid and accurate diagnosis. Additionally, technological advances in molecular diagnostics, such as PCR and next-generation sequencing, have enabled the development of more sensitive and specific tests. Notable companies in the IVD Infectious Disease market include Abbott, Becton Dickinson, Roche, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.